"The most common cause ofaortic aneurysms is atherosclerosis."-Harrison's Textbook ofMedicine, 1 1th ed. (1).
"The most common cause ofaortic aneurysms is atherosclerosis."-Harrison's Textbook ofMedicine, 1 1th ed. (1) .
Two new developments indicate that the statements in standard textbooks about the causes of aortic aneurysms should be reexamined. They also have important implications for the treatment and management of patients and families with the disease.
One recent development was a series of careful studies of families of patients with aortic aneurysms. Rupture of aortic aneurysms accounts for 1-2% ofdeaths in industrialized countries (2, 3) , but no attempts to define the family incidence ofthe disease were carried out until recently (Table I ). Tilson and Seashore were among the first to report a relatively high familial incidence of the disease (4) , and now several groups have confirmed their findings. In one of the most thorough studies, Bengtsson and co-workers (5) used ultrasound to examine the aortas of 87 asymptomatic brothers and sisters of 32 patients who had undergone surgery for abdominal aortic aneurysms. At the time they were examined, 29% ofthe brothers and 6% of the sisters had aortic aneurysms as defined by dilatations of > 2.9 cm at the level ofthe coeliac axis. A similar kind ofstudy was carried out in the United States by Webster et al. (6) who carried out ultrasound screening of 103 first-degree relatives of 43 patients with an abdominal aortic aneurysm. In relatives who were 50 yr or older, 13% of siblings were found to have previously undiagnosed abdominal aortic aneurysm. Similar values for the familial incidence ofthe disease were observed in several studies in which patients and families were interviewed but not examined further (7) (8) (9) (10) (11) (12) .
The reports from these several groups established that aortic aneurysms are familial, and, therefore, strongly suggested that they are caused by genetic defects. The relatively high incidence of affected members of families suggested that the disease is dominantly inherited but a recent statistical evaluation (13) supported recessive inheritance. The family studies did not contradict the general impression that the development of aneurysms is accelerated by atherosclerosis, hypertension, and other factors. In fact, the higher incidence among brothers than sisters of patients strongly suggested a secondary component such as atherosclerosis contributes to the disease. The results, however, strongly suggested that a genetic defect unrelated to any genetic defect causing atherosclerosis or hypertension is the underlying cause of most aortic aneurysms.
Receivedfor publication 30 May 1991. Of special interest is the observation that although most affected members of the families studied develop aneurysms only of the aorta, some also develop cerebral aneurysms (14) . Therefore, the results raised the possibility that both aortic and cerebral aneurysms have a common genetic cause.
The second recent development came from analysis of collagen genes. Research over the past 10 years has demonstrated that mutations in either of the two structural genes for type I procollagen are the most common cause ofosteogenesis imperfecta ("brittle bone disease"). Over 90% of patients with osteogenesis imperfecta have been shown to have mutations in the genes for type I procollagen and over 70 different mutations have been found in unrelated patients with the disease (15) . With a few exceptions, the mutations cause synthesis of structurally abnormal but partially functional proa chains of type I procollagen that either interfere with the normal assembly of the type I procollagen molecule or interfere with the assembly of collagen fibrils by normal type I collagen synthesized by the same fibroblasts from heterozygous probands. The disastrous effects of the mutations, therefore, are largely explained by the fact that fibers of type I collagen are a major source of the structural strength of bone. The mutations either decrease the amount of type I collagen fiber synthesized or generate abnormal fibrils. In parallel experiments, several patients with severe chondrodysplasias were found to have similar mutations in the gene for type II procollagen, the precursor of type II collagen that is a major source of the strength of cartilage (15) . Also, mutations in the gene for type III procollagen were found in a series of patients (16) (17) (18) (19) (20) (21) (22) (23) with the type IV variant of EhlersDanlos syndrome (24) (25) (26) (27) that is characterized by sudden death from rupture of the aorta and other hollow organs such as the intestine. Again, the consequences of the mutations are largely explained by the fact that the tensile strength of large blood vessels largely depends on fibrils of type III collagen that are very similar in structure and function to the fibrils oftype I collagen found in bone and the fibrils oftype II collagen found in cartilage. More recently, evidence suggesting a mutation in type I procollagen was reported in two unrelated families with osteopenia and a mutation in the proa2(I) gene was defined in a woman who presented with postmenopausal osteoporosis (15) . Also, linkage studies suggested mutations in the gene for type II procollagen in two families with osteoarthritis and a mutation in the type II procollagen gene was found in affected members ofone large family with osteoarthritis associated with a chondrodysplasia (15) .
For these and related reasons, we initiated a series ofexperiments to test the hypothesis that mutations in the gene for type III procollagen might be a cause ofaortic aneurysms in families without any other evidence of genetic disease. A mutation in the type III at the age of34 from diffuse bleeding ofthe aorta (28). The man had a history of easy bruisability and bleeding, but none of the dramatic skin changes usually associated with type IV EhlersDanlos syndrome such as ecchymoses, scarring, and heavy pigmentation. He, therefore, probably represented phenotypic overlap between Ehlers-Danlos syndrome type IV and familial aneurysms. Subsequently, we found a mutation in the type III procollagen gene (29) in a 37-yr-old woman who was in excellent health but was concerned because of a strong family history of sudden death from ruptured aortic aneurysms (Fig. 1) . The mutation converted the codon for glycine at amino acid position a 1-619 to a codon for arginine and decreased the thermal stability of fragments from type III procollagen synthesized by her cultured skin fibroblasts. The same mutation in the type III procollagen gene was found in surgical specimens of the aorta from her aunt who died in 1986 with multiple aneurysms of the aorta and related arteries at the age of 55. Also, the same mutation was found in tissue from a microscopic slide from the aorta of her mother who died of a ruptured aortic aneurysm at the age of 34 in 1960 (Fig. 2) . Assays with the polymerase chain reaction on samples of saliva from several members of the family demonstrated that five family members inherited the mutation (29) . Periodic ultrasound examination has recently demonstrated a developing aortic aneurysm in one of the five individuals. The family studies and gene analyses provide several conclusions about aortic aneurysms. One conclusion is that they are frequently familial and, therefore, probably genetic in these families. The other conclusion is that mutations in the gene for type III procollagen, the precursor ofa major structural protein of the aorta, are a cause of aortic aneurysms in some families and may well be in many others. To date, the type III procollagen gene has been analyzed only in less than 20 families with aortic aneurysms and the analyses that have been carried out are incomplete. Therefore, it is clear that more gene analyses must be performed in such families on the gene for type III procollagen, as well as on genes for other structural proteins that may contribute to the strength of the aorta.
These conclusions have very direct implications for the management of patients and families with aortic aneurysms. Early surgical treatment ofthe disease is clearly ofgreat benefit. Numerous reports have demonstrated that individuals who undergo elective surgery for the repair ofaortic aneurysms have a survival rate of> 90%, and many apparently have a normal life span (30, 31) . In contrast, the survival rate among individuals who begin to hemorrhage can be as low as 10% (1 1). Also, the hospitalization costs for individuals who undergo elective repair of aortic aneurysms is about one-tenth the cost of surgical repair in individuals whose aneurysms have begun to bleed. For these reasons, a DNA diagnostic test for mutations causing aortic aneurysms is clearly of benefit to families in whom such mutations can be identified.
At the moment, there are several limitations to DNA diagnostic tests for aortic aneurysms. The gene for type III procollagen is large and contains 52 exons, any one ofwhich could have a mutation that causes aneurysms. Therefore, extensive gene analyses are required to identify the mutation in a new family. Fortunately, improved technologies have reduced the time to sequence a large gene such as the type III procollagen gene from > 2 yr to less than -1 wk (32) (33) (34) (35) (36) (37) (38) . The techniques are continually being improved and, therefore, it is reasonable to expect that in time such analyses will be commonly available to clinicians and to families. Once the mutation in a type III procollagen gene causing aneurysms in a family is defined, it is relatively easy to screen DNA from saliva and other sources from EU 0 aneuwysm Li 60 mutated gene Wa G normal gene other members of the family for the presence or absence ofthe mutation. As recent studies have illustrated (Fig. 1) , it is possible to definitively identify individuals who have not inherited the mutation and, therefore, are not at increased risk to develop an aneurysms. At the same time, it is possible to identify individuals who have increased risk for developing aneurysms and, therefore, should be regularly followed by sonography or other noninvasive techniques. Even in the absence of a definitive DNA test, however, the high incidence ofaortic aneurysms among family members of patients with the disease strongly suggest that direct blood relatives should be followed by sonography at regular intervals. And the idea that atherosclerosis is a primary cause of aortic aneurysms must either be carefully reexamined or totally abandoned.
